This Day One Biopharmaceuticals Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Day One Biopharmaceuticals, Inc. +0.09% Pre
Talkspace, Inc. +0.19% Pre
Associated Capital Group, Inc. Class A 0.00% Pre
Day One Biopharmaceuticals, Inc. DAWN | 21.47 21.48 | +0.09% +0.05% Pre |
Talkspace, Inc. TALK | 5.18 5.18 | +0.19% 0.00% Pre |
Associated Capital Group, Inc. Class A AC | 0.00% 0.00% Pre |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Keybanc analyst Steve Dechert downgraded the rating for Talkspace Inc (NASDAQ:TALK) from Overweight to Sector Weight. Talkspace shares closed at $5.12 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Andres Y. Maldonado downgraded Day One Biopharmaceuticals Inc (NASDAQ:DAWN) from Buy to Neutral and cut the price target from $22 to $21.5. Day One Biopharmaceutical shares closed at $21.33 on Monday. See how other analysts view this stock.
- Scotiabank analyst Konark Gupta downgraded Air Canada (TSX:AC) from Sector Outperform to Sector Perform and cut the price target from C$27 to C$21. See how other analysts view this stock.
Considering buying DAWN stock? Here’s what analysts think:
Photo via Shutterstock
